Core Laboratories (CLB) Share-based Compensation (2022 - 2026)

Core Laboratories' Share-based Compensation history runs 5 years deep, the most recent figure standing at $5.0 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 20.99% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $8.0 million, a 158.92% increase from a year earlier, with the FY2025 full-year figure at $7.1 million, up 90.07% from the prior year.
• Share-based Compensation grew to $5.0 million in Q1 2026 per CLB's latest filing, from $1.1 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $9.0 million in Q1 2023 and bottomed at -$1.0 million in Q2 2022.
• The 5-year median for Share-based Compensation is $1.3 million (2023), against an average of $2.0 million.
• Across the five-year window, Share-based Compensation slumped 129.27% in 2024 and soared 508.33% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $304000.0 in 2022, then surged by 414.8% to $1.6 million in 2023, then slumped by 129.27% to -$458000.0 in 2024, then surged by 343.23% to $1.1 million in 2025, then surged by 351.71% to $5.0 million in 2026.
• Per Business Quant, the three latest CLB Share-based Compensation figures stand at $5.0 million (Q1 2026), $1.1 million (Q4 2025), and $1.3 million (Q3 2025).